2nd Masterclass in Endoscopy in Gastrointestinal Oncology
30 ESCO credits
31.01.2020 - 03.02.2020
Nijmegen, The Netherlands
MASTERCLASS
Description
Chairs: M. Conio, IT - P.D. Siersema, NL - M. Wallace, US
The aim of this Masterclass is to provide an update of the role of endoscopy in the diagnosis and treatment of gastrointestinal neoplasia. The Masterclass is specifically addressed to junior specialists and each topic will be analysed in a systematic and propaedeutic way, from basic to the most complex and difficult procedures. The Masterclass will consist of a series of focused presentations, update lectures and video sessions. Presenters will be using case illustrative examples and high quality video throughout the programme.
The most recent advances in diagnostic and therapeutic endoscopy will be presented; technical devices will be critically analysed according to the data obtained from evidence-based results of the literature.
High level interaction between the faculty and the audience will be facilitated throughout the course and clinical case discussions in groups will be scheduled each day where the participants’ clinical cases will be discussed. The importance of the multidisciplinary approach to gastrointestinal cancers will be elaborated.
Together with gastroenterologists, interventional radiologists, surgeons and oncologists, participants will be actively involved both in the presentations and in the discussions.
The key aim of the course is to illustrate that endoscopy may offer its best potential particularly when it is part of a comprehensive clinical evaluation of the patient.
LEARNING OBJECTIVES
• Update on epidemiology of gastrointestinal cancers and precancerous conditions/lesions
• Appraise the role of endoscopy in several scenarios.
• Discuss cancer genetics and the role of endoscopy.
• Update on endoscopic diagnostic approaches and endotherapy in a multidisciplinary perspective.
• Update on technological innovations.
• Discuss indications and limits of endoscopy and methods to acquire competency in endoscopy.
• Competency in endoscopy but also in clinical research: how to prepare a research protocol
TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines, which will be concluded in take-home messages.
Participants will deliver case presentations within small groups and discuss these with the chairs and the faculty.
Admitted participants will be requested to take part in the whole event. The Masterclass will be entirely in English and fluency in English is necessary for admission.
THE MASTERCLASS:
• Is a 4-day residential, educational and practical event
• Presents full covering of premalignant lesions and malignancies of the gastrointestinal tract
• Is clinically and multi-disciplinary-oriented
• Includes an international faculty of top experts delivering lectures and holding interactions focusing on the management of esophageal, gastric, hepatobiliary, pancreatic and colon cancer
• Provides interaction with other junior specialists from various countries and the experts
• Is located at a teaching hospital
Held in collaboration with: | |||
A.R.G.O |
|||
Under the auspices of: | |||
Endorsed by: | |||
Under the patronage of: |
Faculty
FACULTY
M. Conio, Ospedale Santa Corona, Gastroenterology Unit, Pietra Ligure, IT
I. Gralnek, Emek Medical Center, Gastroenterology Dept., Afula, IL
L. Moons, University Medical Center Utrecht, Gastroenterology & Hepatology, Utrecht, NL
M. Müller, DKD Helios Klinik Wiesbaden, Department of Gastroenterology, Weisbaden, DE
M. Mutignani, ASST Grande Ospedale Metropolitano Niguarda, Digestive Endoscopy Dept, Milan, IT
I. Nagtegaal, Radboud University Medical Center, Dept. of Patholohy, Njimegen, NL
H. Neumann, University Medical Center Mainz, Interdisciplinary Endoscopy Center, Mainz, DE
M. Palazzo, European Hospital of Marseille, Digestive Disease Medical Department., Aix-en-Provence, FR
M. Pennazio, City of Health and Science University Hospital, University Division of Gastroenterology, Turin, IT
R. Pouw, Amsterdam University Medical Center, Gastroenterology Dept., Naarden, NL
J. Regula, Institute of Oncology, Medical Centre for Postgraduate Education, Gastroenterology Dept.,Warsaw, PL
S. Rodriguez, Ruber Juan Bravo Hospital, Gastroenterology and Hepatology Service, Madrid, ES
P.D. Siersema, Radboud University Medical Center, Dept. of Gastroenterology and Hepatology, Njimegen, NL
M. Spaander, University Medical Centre Rotterdam, Department of Gastroenterology, Rotterdam, NL
P.J. Tanis, Academic Medical Centre, Department of surgery, Amsterdam, NL
E. Vazquez-Sequeiros, Hospital Universitario Ramón y Cajal, Dept. of Gastroenterology, Madrid, ES
R. Verhoeven, Netherlands Comprehensive Cancer Organisation, Research & Development Dept, Utrecht, NL
M. Wallace, Mayo Clinic, Gastrointestinal Dept. Jacksonville, US
P. Zhou, Fundan University, Zhongsham Hospital, Shanghai, CN
General information
ORGANISING SECRETARIAT
European School of Oncology
Piazza Indipendeza 2, 6500 Bellinzona, Switzerland
Luis Carvalho, Ph: +41 91 820 09 58, E-mail: lcarvalho@eso.net
ACCREDITATION
Participants will be entitled to receive a certificate of attendance at the close of the Masterclass by completing the online evaluation questionnaire.
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 21 European CME credits (ECMEC).
LANGUAGE
The Masterclass will be held in English and translation will not be provided.
INSURANCE
The organizers bear no responsibility for untoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance coverage.
Application
PARTICIPATION
Attendance is limited to 50 participants and admittance is by competitive application only.
Successful applicants are granted free registration but a contribution to the total cost of the masterclass (EUR 300 for 3-night stay) and travel are to be covered by the participants.
IDEAL PROFILE OF THE MASTERCLASS CANDIDATE
• Young specialists (40 years or younger) in gastroenterology and endoscopy
• Interest in clinical research
• Fluency in English
ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
THE APPLICATION DEADLINE HAS PASSED (27 OCTOBER 2019)
Programme
31 January
13:30 | Registration | |
14:00 | Welcome Chairs |
|
INTRODUCTORY SESSION | ||
14:15 | Gastrointestinal cancers - Epidemiology and risk factors R. Verhoeven, NL |
|
BARRETT'S ESOFAGUS | ||
14:35 | Surveillance of Barrett’s esophagus - Is it worth the effort or can it be stopped in subgroups of patients? R. Pouw, NL |
|
14:55 | When to perform esophageal resection or ablation in Barrett’s esophagus? M. Wallace, US |
|
15:15 | Coffee break | |
14:45 | When is endoscopic resection considered curative and when to perform surgery? R. Pouw, NL |
|
16:05 | Discussion | |
16:35 | Video session M. Conio, IT - R. Pouw, NL - M. Wallace, US |
|
17:00 | Group sessions (3 groups) Chairs Clinical case presentations by participants (3 x 5 cases x 15') |
|
SMALL BOWEL TUMORS |
||
18:35 | Update lecture: Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel tumors M. Pennazio, IT |
|
18:55 | Discussion | |
19:15 | Bus to the hotel | |
20:00 | Welcome dinner at the hotel |
1 February
8:20 | Bus to the venue | |
ESOPHAGUS - ESOPHAGEAL CANCER | ||
9:00 | Novel developments in endoscopic mucosal imaging M. Wallace, US |
|
9:20 | Update lecture: When to perform endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for early esophageal squamous cancer? P. Zhou, CN |
|
9:50 | Palliation of advanced esophageal cancer P. Siersema, NL |
|
10:10 | Discussion | |
10:25 | Video session P. Siersema, NL - M. Wallace, US - P. Zhou, CN |
|
11:00 | Coffee break | |
ESOPHAGUS - POTPOURRI | ||
11:30 | Treatment options for achalasia, including long-term effects P. Zhou, CN |
|
11:50 | Endoscopic management of post-esophagectomy anastomotic complications (strictures, perforations) M. Conio, IT - P. Siersema, NL |
|
12:10 | Discussion | |
12:20 | Video session M. Conio, IT - P. Siersema, NL - P. Zhou, CN |
|
12:55 | Lunch | |
STOMACH - (EARLY) GASTRIC TUMOR AND OTHER TUMORS | ||
13:55 | Update lecture: Endoscopic and clinicopathological characteristics of early gastric cancer P. Zhou, CN |
|
14:15 | Surveillance of atrophic gastritis in Western countries – fact or fiction? M. Spaander, NL |
|
14:35 | Endoscopic removal of mucosal submucosal tumors in the stomach P. Zhou, CN |
|
14:55 | Discussion | |
15:10 | Video session M. Spaander, NL - P. Zhou, CN |
|
16:00 | Coffee break | |
16:30 | Update lecture: Quality improvement initiatives in gastrointestinal endoscopy P. Zhou, CN |
|
16:50 | Update lecture: Non-anesthetist propofol sedation: what is needed to administer it safely? M. Müller, DE |
|
17:10 | Discussion | |
17:20 | Group sessions (3 groups) Chairs Clinical case presentations by participants (3 x 5 cases x 15') |
|
19:00 | Bus to the hotel |
2 February
8:20 | Bus to the venue | |
PANCREATICOBILIARY CANCER | ||
9:00 | Tips and tricks for a successful ERCP in pancreaticobiliary malignancies M. Mutignani, IT |
|
9:20 | Update lecture: The role of endoscopic ultrasound guided interventions in pancreaticobiliary malignancies M. Palazzo, FR |
|
9:40 | How to diagnose and how to treat cystic lesions in the pancreas E. Vazquez-Sequeiros, ES |
|
10:00 | Management of ampullary lesions M. Mutignani, IT |
|
10:20 | Discussion | |
10:35 | Coffee break | |
11:05 | Video session M. Mutignani, IT - E. Vazquez-Sequeiros, ES - M. Palazzo, FR |
|
GI BLEEDING | ||
12:00 | Update lecture: Endoscopy for GI bleeding - old vs. new I. Gralnek, IL |
|
12:15 | Discussion | |
MEDICAL-LEGAL ISSUES AND GI GUIDELINES | ||
12:20 | Update lecture: The legal-clinical role of guidelines in gastrointestinal practice S. Rodriguez, ES |
|
12:35 | Discussion | |
12:40 | Lunch | |
COLON-POLYPS | ||
13:40 | Update lecture: Endoscopic and clinicopathological characteristics of premalignant colorectal lesions H. Neumann, DE |
|
14:00 | The increasing role of the serrated pathway in colorectal cancer I. Nagtegaal, NL |
|
14:20 | Do we need behind-fold technologies to improve our adenoma detection rate? I. Gralnek, IL |
|
14:40 | Cleaning the colon - new developments S. Rodriguez, ES |
|
15:00 | Discussion | |
15:15 | Coffee break | |
15:45 | Colorectal polypectomy for lesions < 2cm: when cold, when hot, and how to do it? M. Wallace, US |
|
16:00 | Discussion | |
16:05 | Video session I Gralnek, IL - I. Nagtegaal, NL - M. Wallace, US - H. Neumann, DE - S. Rodriguez, ES |
|
17:05 | Group sessions (3 groups) Chairs Clinical case presentations by participants (3 x 5 cases x 15') |
|
19:00 | Bus to the hotel | |
20:00 | Bus to the farewell dinner | |
20:30 | Farewell dinner |
3 February
8:30 | Bus to the venue (after hotel check-out) | |
COLON-POLYPS (CONT.) | ||
9:00 | When to perform EMR and when ESD in colorectal premalignant changes and early cancer? M. Conio, IT |
|
9:20 | Update lecture: Challenges in T1 colorectal cancer L. Moons, NL |
|
9:40 | Discussion | |
9:55 | Video Session M. Conio, IT - L. Moons, NL |
|
10:40 | Coffee break | |
COLON - COLORECTAL CANCER | ||
11:10 | How to perform screening for colorectal cancer: FOBT/FIT/stool DNA, capsule, scope or CT J. Regula, PL |
|
11:30 | Colonoscopic surveillance in inflammatory bowel disease H. Neumann, DE |
|
11:50 | Palliation in colorectal cancer - Stent or surgery? P.J. Tanis, NL |
|
12:10 | Discussion | |
12:35 | Video session J. Regula, PL - H. Neumann, DE - M. Conio, IT - L. Moons, NL - P.J. Tanis, NL |
|
13:05 | Closing remarks, Certificates and lunch box | |
13:20 | Bus to the train station |